Authors


Frank M. Torti, MD, MPH

Latest:

Health System Correlates of Receipt of Radiation Therapy After Breast-Conserving Surgery: A Study of Low-Income Medicaid-Enrolled Women

Omission of radiation therapy after breast-conserving surgery leads to poor outcomes. Geographic isolation and scarcity of healthcare specialists correlate with low adjuvant radiation therapy use.


Jonathan Hashimoto, PharmD

Latest:

Impact of a Pharmacy-Based Transitional Care Program on Hospital Readmissions

Patients receiving postdischarge care from pharmacists had a 28% lower risk of readmission at 30 days and a 31.9% lower risk at 180 days compared with usual care.






Grace Wang, PhD, MPH

Latest:

Digital Musculoskeletal Program Is Associated With Decreased Joint Replacement Rates

Adults with osteoarthritis who took part in a digital musculoskeletal program had lower rates of knee and hip arthroplasty at 12 months vs those using traditional care.



Christian D. Helfrich, PhD, MPH

Latest:

Changes in Electronic Notification Volume and Primary Care Provider Burnout

Primary care provider burnout was analyzed before and after a national initiative to optimize the electronic health record inbox notification system at the Veterans Health Administration.



Mark B. McClellan, MD, PhD

Latest:

Prospective or Retrospective ACO Attribution Matters for Seriously Ill Patients

This study compared beneficiary characteristics and Medicare per capita expenditures among seriously ill Medicare accountable care organization (ACO) populations defined using prospective and retrospective claims-based attribution methods.





Sigrid Mohnen, PhD

Latest:

Bundled Payments for Diabetes Care and Healthcare Costs Growth: A 2-Year Follow-up Study

Disease management programs for diabetes care based on bundled payment did not slow down the cost growth. Multimorbid adult patients with diabetes had largest cost growth.



Joshua P. Metlay, MD, PhD

Latest:

Unintended Consequences of a Quality Measure for Acute Bronchitis

A quality measure reduced antibiotic use for patients with acute bronchitis but led to use of an alternative diagnosis, offsetting most of the observed improvement.




Emily Allinder Scott, MHA

Latest:

Improving Population Health Through Multistakeholder Partnerships

Improving population health requires developing innovative multistakeholder partnerships to enable mining and cross-leveraging data sets, creating patient touchpoint “ecosystems,” and aligning investments with each stakeholder’s returns.


Michael A. Horberg, MD

Latest:

Patient Experience After Modifying Visit Delivery During the COVID-19 Pandemic

Coronavirus disease 2019 (COVID-19) was associated with immediate weekly visit trend decreases for overall, primary care, and specialty care with long-term recovery trends; transformation to virtual visits; and increasing long-term trends for meeting patient scheduling and visit needs.


Timothy J. Day, MSPH

Latest:

Patient Experience During a Large Primary Care Practice Transformation Initiative

Four years of practice transformation toward comprehensive primary care had little effect on patient experience.



Amal Trivedi, MD

Latest:

Medicare Advantage Control of Postacute Costs: Perspectives From Stakeholders

This qualitative study examines the methods that Medicare Advantage plans use to control or reduce postacute spending and their associated unintended consequences.


Arthur J. Davidson, MD, MSPH

Latest:

Care by Cell Phone: Text Messaging for Chronic Disease Management

Cell phone“based text messaging may be used to feasibly support chronic disease management and engagement in diabetes self-care behaviors for some patients.



Peter W. Crooks, MD

Latest:

Clinical Outcomes and Healthcare Use Associated With Optimal ESRD Starts

Optimal end-stage renal disease (ESRD) starts were associated with lower 12-month morbidity, mortality, and inpatient and outpatient utilization in an integrated healthcare delivery system.



value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. [published online April 3, 2018]. J Med Econ. doi: 10.1080/13696998.2018.1457533.

Latest:

Study Summary: Estimating the Value-Based Price Range of Erenumab for Migraine Prevention

This health economic analysis predicted that, compared with use of supportive care, erenumab treatment will reduce the direct and indirect costs associated with migraine and increase quality-adjusted life-years for patients who have previously experienced treatment failure with at least 1 preventive migraine treatment.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo